Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
535.00    10.00 (1.90%)
Bid:
531.00
Ask:
535.00
Spread: 4.00 (0.753%)
Market Cap: £307.86m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Statement

25 May 2021 07:00

RNS Number : 6501Z
Mortgage Advice Bureau(Holdings)PLC
25 May 2021
 

25 May 2021

Mortgage Advice Bureau (Holdings) plc

AGM Statement

Mortgage Advice Bureau (Holdings) plc ("MAB"), one of the UK's leading consumer intermediary brands and specialist Appointed Representative ("AR") networks, will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"Adviser numbers have continued to grow since our final results statement on 23 March 2021 and had risen to 1,6681 advisers by 21 May 2021, an increase of 6% year to date. Our new AR and adviser pipeline has been continuing to build and is at an all-time high. Those discussions that were on hold during lockdown have now resumed and we expect them to conclude quickly.

"MAB's mortgage completions for Q1 2021 were £5.3bn, representing an increase of 26% on Q1 2020. We are pleased with this strong performance and the increase in both written and banked adviser productivity.

"Activity levels in the housing market have continued to be high throughout April and May. In addition, the underlying fundamentals driving consumer demand for housing purchase remain unchanged.

"Rapid progress continues to be made in terms of securing new lead sources and the development of our lead management platform.

"We had a strong start to the year in the first quarter, with considerably improved year on year profitability. This positive momentum has continued into the second quarter and trading continues to be strong. Current trading is in line with the Board's expectations."

1 Includes 42 Advisers of a firm previously authorised under an Appointed Representative agreement with MAB until 7 December 2020. MAB continues to provide services to this firm, now directly authorised by the FCA.

Enquiries:

Mortgage Advice Bureau (Holdings) plc  +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: 

Numis Securities Limited Tel: +44 (0)20 7260 1000

Stephen Westgate / Hugo Rubinstein / Laura White (Corporate Finance)

Media Enquiries: 

investorrelations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDKQBBOBKDFPB
Date   Source Headline
28th Feb 202010:04 amRNSDirector/PDMR Shareholding
26th Feb 20204:41 pmRNSSecond Price Monitoring Extn
26th Feb 20204:35 pmRNSPrice Monitoring Extension
17th Feb 202010:34 amRNSDirector/PDMR Shareholding
3rd Feb 20204:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20204:35 pmRNSPrice Monitoring Extension
3rd Feb 20202:13 pmRNSHolding(s) in Company
31st Jan 202012:23 pmRNSDirector/PDMR Shareholding
28th Jan 20207:00 amRNSTrading Update
14th Jan 20205:46 pmRNSDirector/PDMR Shareholding
31st Dec 20199:23 amRNSDirector/PDMR Shareholding
16th Dec 20194:13 pmRNSDirector/PDMR Shareholding
12th Dec 201910:18 amRNSBlock listing Interim Review
2nd Dec 20197:00 amRNSDirector/PDMR Shareholding
14th Nov 20193:05 pmRNSDirector/PDMR Shareholding
31st Oct 201912:34 pmRNSDirector/PDMR Shareholding
25th Oct 20194:02 pmRNSDirector/PDMR Shareholding
22nd Oct 20195:13 pmRNSHolding(s) in Company
22nd Oct 20195:09 pmRNSHolding(s) in Company
14th Oct 20194:31 pmRNSDirector/PDMR Shareholding
30th Sep 20193:18 pmRNSHolding(s) in Company
30th Sep 20193:13 pmRNSDirector/PDMR Shareholding
24th Sep 20197:00 amRNSHalf-year Report
17th Sep 20196:25 pmRNSDirector/PDMR Shareholding
30th Aug 20192:22 pmRNSDirector/PDMR Shareholding
29th Aug 201912:07 pmRNSSecond Price Monitoring Extn
29th Aug 201912:02 pmRNSPrice Monitoring Extension
27th Aug 201912:07 pmRNSSecond Price Monitoring Extn
27th Aug 201912:02 pmRNSPrice Monitoring Extension
23rd Aug 201912:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201912:02 pmRNSPrice Monitoring Extension
22nd Aug 201912:07 pmRNSSecond Price Monitoring Extn
22nd Aug 201912:02 pmRNSPrice Monitoring Extension
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn
21st Aug 201912:02 pmRNSPrice Monitoring Extension
20th Aug 201912:07 pmRNSSecond Price Monitoring Extn
20th Aug 201912:02 pmRNSPrice Monitoring Extension
19th Aug 201912:07 pmRNSSecond Price Monitoring Extn
19th Aug 201912:02 pmRNSPrice Monitoring Extension
14th Aug 20194:07 pmRNSDirector/PDMR Shareholding
13th Aug 201912:07 pmRNSSecond Price Monitoring Extn
13th Aug 201912:02 pmRNSPrice Monitoring Extension
7th Aug 20199:06 amRNSReplacement: Director/PDMR Shareholding
31st Jul 20195:46 pmRNSDirector/PDMR Shareholding
31st Jul 201912:07 pmRNSSecond Price Monitoring Extn
31st Jul 201912:02 pmRNSPrice Monitoring Extension
29th Jul 201912:07 pmRNSSecond Price Monitoring Extn
29th Jul 201912:02 pmRNSPrice Monitoring Extension
26th Jul 201912:07 pmRNSSecond Price Monitoring Extn
26th Jul 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.